Initial Therapeutics
2 articles about Initial Therapeutics
-
Initial Therapeutics Names Peter DiLaura as CEO
4/18/2024
Initial Therapeutics Inc. has appointed Peter DiLaura as President and Chief Executive Officer and a member of the company's Board of Directors, effective immediately.
-
Rapport Therapeutics tops this year’s list with $250 million in Series A and B financing in just six months.